Since 2009 MiCo BioMed has been a game-changer and an innovator in the global Point-of-Care testing (POCT) market, shedding light on a new diagnostic paradigm with our groundbreaking Lab-on-a-Chip (LabChip) technology.

With our LabChip-based real-time PCR, we have been able to offer faster, simpler, more affordable and adaptable POCT solutions without compromising accuracy. Amidst the current crisis, we stand firmly at the forefront of the global fight against COVID-19 pandemic, providing comprehensive diagnostic solutions and paving the way back to normality.